Rebexsess Discovery Chemistry specializes in advanced contract research services that leverage 3D protein structure-based rational design and modeling. Their expertise allows for the creation of innovative small molecules and engineered proteins, which serve as novel enzymes. This dual capability enhances their effectiveness in both drug discovery and protein/enzyme engineering, significantly reducing the timeline and costs associated with the discovery phase. By integrating multidisciplinary approaches, Rebexsess aims to minimize risks during clinical trials and contribute to cost control in chemical production and commercialization across various industrial applications.

The company offers a range of services that include Structure Based Drug Design (SBDD), Structure Based Enzyme Engineering (SBEE), and computational chemistry, all of which have demonstrated success in addressing complex challenges in drug discovery and enzyme engineering. Their computational modeling services have been instrumental in the development of significant pharmaceutical products, such as Telaprevir, an anti-hepatitis C drug. By combining structure-based design with medicinal chemistry and synthetic biology, Rebexsess provides comprehensive solutions for small molecule discovery, enzymatic engineering, and project management, ensuring high-quality results for their clients.

United States

Rebexsess is a Chemistry Custom Research Services company that offers computational chemistry, structure-based drug design, and medicinal chemistry consulting with effective outsourcing management.

Rebexsess Discovery Chemistry

Company Details